Literature DB >> 30959108

MBOAT7 is anchored to endomembranes by six transmembrane domains.

Andrea Caddeo1, Oveis Jamialahmadi2, Giovanni Solinas1, Arturo Pujia3, Rosellina Margherita Mancina1, Piero Pingitore1, Stefano Romeo4.   

Abstract

Membrane bound O-acyltransferase domain- containing 7 (MBOAT7, also known as LPIAT1) is a protein involved in the acyl chain remodeling of phospholipids via the Lands' cycle. The MBOAT7 is a susceptibility risk genetic locus for non-alcoholic fatty liver disease (NAFLD) and mental retardation. Although it has been shown that MBOAT7 is associated to membranes, the MBOAT7 topology remains unknown. To solve the topological organization of MBOAT7, we performed: A) solubilization of the total membrane fraction of cells overexpressing the recombinant MBOAT7-V5, which revealed MBOAT7 is an integral protein strongly attached to endomembranes; B) in silico analysis by using 22 computational methods, which predicted the number and localization of transmembrane domains of MBOAT7 with a range between 5 and 12; C) in vitro analysis of living cells transfected with GFP-tagged MBOAT7 full length and truncated forms, using a combination of Western Blotting, co-immunofluorescence and Fluorescence Protease Protection (FPP) assay; D) in vitro analysis of living cells transfected with FLAG-tagged MBOAT7 full length forms, using a combination of Western Blotting, selective membrane permeabilization followed by indirect immunofluorescence. All together, these data revealed that MBOAT7 is a multispanning transmembrane protein with six transmembrane domains. Based on our model, the predicted catalytic dyad of the protein, composed of the conserved asparagine in position 321 (Asn-321) and the preserved histidine in position 356 (His-356), has a lumenal localization. These data are compatible with the role of MBOAT7 in remodeling the acyl chain composition of endomembranes.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acyltransferase; Arachidonic acid (AA) (ARA); Lipid metabolism; MBOAT7; Membrane protein; Phosphatidylinositol; Protein structure; Protein topology; Transmembrane domain

Mesh:

Substances:

Year:  2019        PMID: 30959108     DOI: 10.1016/j.jsb.2019.04.006

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  10 in total

Review 1.  Alcohol effects on hepatic lipid metabolism.

Authors:  Sookyoung Jeon; Rotonya Carr
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

2.  Functional and Structural Changes in the Membrane-Bound O-Acyltransferase Family Member 7 (MBOAT7) Protein: The Pathomechanism of a Novel MBOAT7 Variant in Patients With Intellectual Disability.

Authors:  Jiwon Lee; Amen Shamim; Jongho Park; Ja-Hyun Jang; Ji Hye Kim; Jeong-Yi Kwon; Jong-Won Kim; Kyeong Kyu Kim; Jeehun Lee
Journal:  Front Neurol       Date:  2022-04-18       Impact factor: 4.086

Review 3.  MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD.

Authors:  Marica Meroni; Miriam Longo; Anna L Fracanzani; Paola Dongiovanni
Journal:  EBioMedicine       Date:  2020-07-03       Impact factor: 8.143

4.  Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan.

Authors:  Asad Mehmood Raja; Ester Ciociola; Imran Nazir Ahmad; Faisal Saud Dar; Syed Muhammad Saqlan Naqvi; Muhammad Moaeen-Ud-Din; Ghazala Kaukab Raja; Stefano Romeo; Rosellina Margherita Mancina
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

Review 5.  PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease.

Authors:  Xiaocheng Charlie Dong
Journal:  Front Med (Lausanne)       Date:  2019-12-17

6.  Homozygous variants in the HEXB and MBOAT7 genes underlie neurological diseases in consanguineous families.

Authors:  Shazia Khan; Lettie E Rawlins; Gaurav V Harlalka; Muhammad Umair; Asmat Ullah; Shaheen Shahzad; Muhammad Javed; Emma L Baple; Andrew H Crosby; Wasim Ahmad; Asma Gul
Journal:  BMC Med Genet       Date:  2019-12-18       Impact factor: 2.103

7.  LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover.

Authors:  Yuki Tanaka; Yuta Shimanaka; Andrea Caddeo; Takuya Kubo; Yanli Mao; Tetsuya Kubota; Naoto Kubota; Toshimasa Yamauchi; Rosellina Margherita Mancina; Guido Baselli; Panu Luukkonen; Jussi Pihlajamäki; Hannele Yki-Järvinen; Luca Valenti; Hiroyuki Arai; Stefano Romeo; Nozomu Kono
Journal:  Gut       Date:  2020-04-06       Impact factor: 23.059

Review 8.  New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease.

Authors:  Yu-Cheng Lin; Chi-Chien Wu; Yen-Hsuan Ni
Journal:  Front Pediatr       Date:  2020-12-09       Impact factor: 3.418

9.  Loss of hepatic Mboat7 leads to liver fibrosis.

Authors:  Veera Raghavan Thangapandi; Oskar Knittelfelder; Mario Brosch; Eleonora Patsenker; Olga Vvedenskaya; Stephan Buch; Sebastian Hinz; Alexander Hendricks; Marina Nati; Alexander Herrmann; Devavrat Ravindra Rekhade; Thomas Berg; Madlen Matz-Soja; Klaus Huse; Edda Klipp; Josch K Pauling; Judith Ah Wodke; Jacobo Miranda Ackerman; Malte von Bonin; Elmar Aigner; Christian Datz; Witigo von Schönfels; Sophie Nehring; Sebastian Zeissig; Christoph Röcken; Andreas Dahl; Triantafyllos Chavakis; Felix Stickel; Andrej Shevchenko; Clemens Schafmayer; Jochen Hampe; Pallavi Subramanian
Journal:  Gut       Date:  2020-06-26       Impact factor: 23.059

Review 10.  Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.

Authors:  Oriol Juanola; Sebastián Martínez-López; Rubén Francés; Isabel Gómez-Hurtado
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.